Metabolic syndrome prevalence in Iran: a systematic review and meta-analysis

Authors

Farajolah Maleki1, Fatemeh Sayehmiri2,*, Faezeh Kiani2, Kourosh sayehmiri3, Sadaf Nasiri2
1Dept. of Clinical Biochemistry, School of Medicine and Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam,, Iran
2Student Research Committee, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
3Dept. of Social Medicine, School of Medicine and Research Center for Prevention of Psychosocial Impairment - Ilam University of Medical Sciences, Ilam, Iran
*Corresponding Author: Corresponding author: Fatemeh Sayehmiri, Student Research Committee, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran, Tel: +98 9188401168 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 18, issue 4; e74115
Published online:Jul 29, 2014
Article type:Research Article
Received:Feb 16, 2014
Accepted:Jul 01, 2014
How to Cite:Maleki F, Sayehmiri F, Kiani F, sayehmiri K, Nasiri S. Metabolic syndrome prevalence in Iran: a systematic review and meta-analysis. J Kermanshah Univ Med Sci. 2014;18(4):e74115. doi: https://doi.org/10.22110/jkums.v18i4.1514

Abstract

Background: Metabolic syndrome (MetS) is a complex of risk factors which increase the risk of cardiovascular diseases, type 2 diabetes, morbidity and mortality in people. The aim of this study was to analyze the prevalence of MetS in Iran using a meta-analysis study.

Methods: The SID, Magiran, Irandoc, Medlib, Google Scholar and PubMed databases were searched for MetS prevalence. 26 articles conducted between 2003 and 2013 in Iran were selected and the obtained data were analyzed by a meta-analysis using random-effects model. Heterogeneity was assessed using I2 statistics. Data were analyzed by R software and STATA (Ver. 11.2).

Results: The total sample size was 60635 people with the age range of 3-90 years. The metabolic syndrome prevalence based on IDF definition was 36% (95% CI: 0.32-0.40) and based to ATPIII was 27% (95% CI: 0.22-0.32). Based on IDF definition, the MetS prevalence rates in women and men were0.39 (95% CI: 0.19-0.59) and 0.20 (95% CI: 0.10-0.29),  respectively.

Conclusion: The findings showed a high prevalence of metabolic syndrome in Iran, especially in women, which increases with age in both sexes. Health care providers and policy makers need to find solutions to reduce MetS risk in the society.

Highlights

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2014, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Jul
2017

Prevalence of Metabolic Syndrome in Iran: A systematic review and meta-analysis

Sahar Dalvand,
Enayatollah Bakhshi,
Mozhdeh Zarei,
Masoud Taheri Asl,
Reza Ghanei Gheshlagh

Dalvand S, Bakhshi E, Zarei M, Taheri Asl M, Ghanei Gheshlagh R. Prevalence of Metabolic Syndrome in Iran: A systematic review and meta-analysis. Med Surg Nurs J. 2030;5(4):e67928. doi:

25
Sep
2012

Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population

Bahareh AbtaeiNaeini,
Rahimeh Skandarian,
Ali Rashidi,
Mohammad Ebrahim Khamse,
Mojtaba Malek,
Raheb Ghorbani

AbtaeiNaeini B, Skandarian R, Rashidi A, Khamse ME, Malek M, et al. Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population. koomesh. 2012;14(1):e152550. doi:

21
Oct
2018
Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study

Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study

Firoozeh Hosseini-Esfahani,
Zahra Bahadoran,
Nazanin Moslehi,
Golaleh Asghari,
Emad Yuzbashian,
Somayeh Hosseinpour-Niazi
,et al.

Hosseini-Esfahani F, Bahadoran Z, Moslehi N, Asghari G, Yuzbashian E, et al. Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4 (Suppl)):e84771. doi: https://doi.org/10.5812/ijem.84771

30
Nov
2014

Prevalence of metabolic syndrome and its components in over 24 years old population of Qazvin (2012)

Hamid Reza Javadi,
Sima Hashemipour,
Mahnaz Abbasi,
Amir Javadi

Javadi HR, Hashemipour S, Abbasi M, Javadi A. Prevalence of metabolic syndrome and its components in over 24 years old population of Qazvin (2012). J Inflamm Dis. 2024;18(3):e155836. doi:

16
Nov
2021

Prevalence of Metabolic Syndrome and Its Determinants in the Middle-aged and Elderly Population in A Southern Coastal Region, Iran (the PERSIAN Cohort Study): A Cross-sectional Study

Ghazal Zoghi,
Azim Nejatizadeh,
Mehdi Shahmoradi,
Zahra Ghaemmaghami,
Masoumeh Kheirandish

Zoghi G, Nejatizadeh A, Shahmoradi M, Ghaemmaghami Z, Kheirandish M. Prevalence of Metabolic Syndrome and Its Determinants in the Middle-aged and Elderly Population in A Southern Coastal Region, Iran (the PERSIAN Cohort Study): A Cross-sectional Study. Shiraz E-Med J. 2022;23(3):e116838. doi: https://doi.org/10.5812/semj.116838

More by these authors

Farajolah MalekiPubMedScholar
Fatemeh SayehmiriPubMedScholar
Faezeh KianiPubMedScholar
Kourosh sayehmiriPubMedScholar
Sadaf NasiriPubMedScholar
Share
Cited by
Metrics